An overall agreement with the study by Glorieux et al. 37 was observed, with most markers detected at increased abundance in CKD 5 with HD (N = 24) versus combined stages 2–3, except for IGHA1 and SERPINF1, where no significant changes could be detected (Table 2). This evidence concerns the gene SERPINF1 and chronic kidney disease.